Skip to main content
. 2013 Nov 1;13(23):1–45.

Table A3. Risk of Bias Among Observational Trials for the Association Between Homocysteine and the Onset of Dementia.

Author, Year Appropriate Eligibility Criteria Appropriate Measurement of Exposure Appropriate Measurement of Outcome Adequate Control for Confounding Complete Follow-Up
Zylberstein et al, 2011 (33) No limitations No limitations No limitations No limitations No limitations
Seshadri et al, 2002 (34) No limitations No limitations No limitations No limitations No limitations
Kivipelto et al, 2009 (35) No limitations No limitations No limitations No limitations No limitations
Nurk et al, 2005 (36) No limitations No limitations No limitations No limitations Limitationsa
Luchsinger et al, 2004 (37) No limitations No limitations No limitations No limitations No limitations
Haan et al, 2007 (38) No limitations No limitations Limitationsb Limitationsc No limitations
Ravaglia et al, 2005 (39) No limitations No limitations No limitations No limitations No limitations
Wang et al, 2001 (40) No limitations No limitations Limitationsd No limitations No limitations
Kalmijn et al, 1999 (41) No limitations No limitations Limitationsb No limitations No limitations
Kim et al, 2008 (42) No limitations No limitations No limitations No limitations No limitations
Rowan et al, 2007 (43) No limitations No limitations No limitations Limitationse No limitations
a

It is unclear how many patients completed full 6 years of follow-up.

b

Studies reported wide confidence intervals.

c

This analysis was not adjusted for age or sex.

d

This study measured vitamin B12 levels, while all other studies measured homocysteine.

e

It is unclear whether the analysis was adjusted.